Shares of Blend Labs, Inc. (BLND) plummeted 11.54% in the pre-market trading session on Friday, following a price target cut by UBS analysts.
UBS reduced its price target for Blend Labs from $4 to $3.50, maintaining a Neutral rating on the stock. This downward revision in the price target appears to have triggered a significant sell-off in the company's shares, as investors reacted cautiously to the news.
Despite the broader analyst consensus of an "Overweight" rating and a mean price target of $5.37, according to FactSet data, UBS's price target cut seems to have weighed heavily on investor sentiment, leading to the substantial pre-market decline.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。